May 22, 2026
Liminatus Pharma (LIMN) Stock: Nasdaq Delisting Warning Sparks Volatile Trading Session
Liminatus Pharma (LIMN) stock soared 31% after Nasdaq delisting warning, then tumbled pre-market. Company has until May 27 to appeal compliance failure.
The post Liminatus Pharma (LIMN) Stock: Nasdaq Delisting Warning Sparks Volatile Trading Session appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Micron (MU) Earnings and PCE Data: Critical Tests for Tech Stocks This Week
- 1 hour ago
Micron (MU) Stock Price Prediction: What to Expect Through 2031
- 1 hour ago
Five Key Stocks and Inflation Data Set to Drive Markets Next Week
- 4 hours ago
SpaceX (SPCX) Stock: 5-Year Price Forecast and Valuation Analysis
- 4 hours ago
OpenAI vs Anthropic IPO Showdown: Which AI Giant Makes the Smarter Investment?